CAT introduces ‘novel’ trial procedure in pharma excessive pricing appeals
The UK’s Competition Appeal Tribunal has introduced a new trial procedure as drugmakers appeal against two excessive pricing decisions from the UK’s antitrust enforcer, asking the parties involved to prepare parts of a pretrial draft judgment that contains all non-contentious facts.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.